| Nov 16 |
Aytu BioPharma First Quarter 2025 Earnings: Beats Expectations
|
| Nov 14 |
Aytu BioPharma Inc (AYTU) Q1 2025 Earnings Call Highlights: A Historic Quarter with Positive ...
|
| Nov 14 |
Aytu BioPharma, Inc. (AYTU) Q1 2025 Earnings Call Transcript
|
| Nov 13 |
Aytu BioPharma GAAP EPS of -$0.20 beats by $0.14, revenue of $16.57M beats by $2.8M
|
| Nov 13 |
Aytu BioPharma Reports Fiscal 2025 First Quarter Operational and Financial Results
|
| Nov 13 |
Earnings Scheduled For November 13, 2024
|
| Nov 12 |
Aytu BioPharma Q1 Earnings Preview
|
| Nov 6 |
Aytu BioPharma to Report Fiscal 2025 First Quarter Operational and Financial Results on November 13, 2024
|
| Oct 14 |
Aytu BioPharma to Participate in the 2024 Maxim Healthcare Virtual Summit
|
| Oct 1 |
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
|
